Benzinga | May 10, 2021 04:18PM EDT

Revolution Medicines Q1 EPS $(0.53) Up From $(0.74) YoY, Sales $10.13M Down From $11.55M YoY

Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.53) per share. This is a 28.38 percent increase over losses of $(0.74) per share from the same period last year. The company reported $10.13 million in sales this quarter. This is a 12.26 percent decrease over sales of $11.55 million the same period last year.